CFDE Data Portal | Search AK3P3

	Label	Description
	AK3P3 associations Collection (Entity type)	Associations for AK3P3_associations
	AK3P3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	AK3P3 Gene (Entity type)	ENSG00000230042 - AK3 pseudogene 3
	GSE224004 GSE224005 CHD4 EWS-FLI1 knockdown 0 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE196035 GSE196037 MEN1 inhibition 9 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 8 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE200538 butyrolactone Hep-G2 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 8 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	CSNK1G3 IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	NPY2R IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG

AK3P3 associations

Associations for AK3P3_associations

AK3P3 associations.tsv

A file from IDG as part of the Harmonizome project

AK3P3

ENSG00000230042 - AK3 pseudogene 3

GSE224004 GSE224005 CHD4 EWS-FLI1 knockdown 0 v 8 human up

A Gene Set from LINCS

GSE196035 GSE196037 MEN1 inhibition 9 v 10 human dn

A Gene Set from LINCS

GSE100148 EZH2 inhibition 8 v 5 human dn

A Gene Set from LINCS

GSE200538 butyrolactone Hep-G2 1 v 2 human dn

A Gene Set from LINCS

GSE100148 EZH2 inhibition 8 v 7 human dn

A Gene Set from LINCS

CSNK1G3 IDG kinase ARCHS4 coexpression

A Gene Set from IDG

NPY2R IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.